Skip to content

The effect of prolotherapy on knee joint wear with effusion

Investigation of the effect of concomitant intraarthicular and periarticular prolotherapy in comparison to intraarticular prolotherapy in knee osteoarthritis with effussin in Reduce pain and improve function

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171215037873N1
Enrollment
40
Registered
2018-05-06
Start date
2018-01-10
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, effusion, knee, prolotherapy. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: Intraarthicular and periarticular prolotherapy and Intraarthicular prolotherapy. Intervention 2: Intervention group: Intra-articular prolotherapy and intra-articula

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: The criteria for entering the study were completing sompleting form of consent, the presence of pain and other clinical symptoms of knee osteoarthritis in the last month

Exclusion criteria

Exclusion criteria: Exculusion criteria : diabetes, Rheumatic diseases and collagen and vascular disease, gout and lupus, radiculopathy, nerve injury and neuropathy, Brucella infection, BMI> 42, history of knee replacement on the affected side , Bleeding disorder, inability to communicate and complete questionnaires, history of allergy and allergic reaction to used drugs, history of significant liver, kidney and cardiovascular disorders, history of injections inside or around the joint in 3 Last month, pregnant women, people who have cancer, people who are on the go Use of anticoagulants.

Design outcomes

Primary

MeasureTime frame
People with knee osteoarthritis with effusion. Timepoint: In both groups before and after treatment in weeks 2 and 4 after the last injection. Method of measurement: The standard questionnaire of VAS, WOMAC, OKS, which is one of the most commonly used outcome measures in the treatment of knee osteoarthritis, was completed. VAS For pain levels, WOMAC is used to check the pain in everyday activities. OKS is also used to assess the amount of pain and the ability to perform various activities.

Secondary

MeasureTime frame
Knee pain recovery, improvement of individual performance in life. Timepoint: In both groups before and after treatment in the 2nd and 4th weeks after the last injection, the standard questionnaire of VAS, WOMAC, OKS, which is one of the most commonly used outcome measures in the treatment of knee osteoarthritis, was completed. Method of measurement: VAS For pain levels, WOMAC is used to check the pain in everyday activities. OKS is also used to assess the amount of pain and the ability to perform various activities.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSharareh Roshanzamir

Shiraz University of Medical Sciences

doroodif@sums.ac.ir+98 71 3231 9040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026